Immunological Characteristics of Maternal-fetal Transmission of Cytomegalovirus in Pregnancy

NCT02129465 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2018-01-03

No results posted yet for this study

Summary

Analysis of several characteristics of blood from pregnant women with CMV infection according to maternal-fetal transmission. These include CMV viral load, cytokine profile in response to in-vitro stimulation with CMV peptides, meticulous analysis of anti CMV antibodies, maternal DNA polymorphism and microarray of gene expression.

Conditions

  • Pregnancy
  • Cytomegalovirus Infections
  • Congenital Infection

Sponsors & Collaborators

  • Shaare Zedek Medical Center

    lead OTHER

Principal Investigators

  • Yechiel Schlesinger, MD · Shaare Zedek Medical Center, Jerusalem, Israel

  • Yifat Eldar-Yedidia, Ph.D. · Shaare Zedek Medical Center, Jerusalem, Israel

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2018-12-31
Completion
2019-05-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02129465 on ClinicalTrials.gov